Re: A new way to stave off recurrence? - Management of breast cancer based on CA27.29 and CA15.3

Steph wrote:

> "J" <questra@xxxxxxxxxxxx> wrote in message
> > Some, on the breast cancer newsgroup, seem to be using the above (markers)
> > to base their treatments/changes decisions and they're quoting the
> > following article.
> >
> > http://www.clinchem.org/cgi/content/full/45/5/630 Clinical Chemistry 45:
> > 630-637, 1999;
> >
> > An example: "Diagnosed stage IV, 1999 with lung mets, she's healthy as a
> > horse, her scans are clear; her chest x-ray is clear; her liver enzymes
> > are fine, no sign of mets, but her markers are rising, on straight
> > Herceptin, so we're back into round 3 of treatments. Both Navelbine and
> > Taxotere have proven to be synergistic with Herceptin and this just might
> > work"
> >
> > Comments?
>
>
> I've given my views on taking treatment because of rising markers many
> times.

Did you read the article? (I checked first and it's never been posted here
before).
Thanks,
J

.

Relevant Pages